The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2012
Filed:
Apr. 29, 2008
Sharmila Bakshi, Vienna, AT;
Thomas Cipps, Vienna, AT;
Markus Hanner, Pressbaum, AT;
Jutta Pikalo, Strau, AT;
Christina Satke, Moedling, AT;
Eszter Nagy, Vienna, AT;
Urban Lundberg, Dresden, DE;
Dagmar Zierer, Vienna, AT;
Andreas Meinke, Pressbaum, AT;
Birgit Noiges, Vienna, AT;
Ulrike Stierschneider, Vienna, AT;
Alexander Von Gabain, Vienna, AT;
Sharmila Bakshi, Vienna, AT;
Thomas Cipps, Vienna, AT;
Markus Hanner, Pressbaum, AT;
Jutta Pikalo, Strau, AT;
Christina Satke, Moedling, AT;
Eszter Nagy, Vienna, AT;
Urban Lundberg, Dresden, DE;
Dagmar Zierer, Vienna, AT;
Andreas Meinke, Pressbaum, AT;
Birgit Noiges, Vienna, AT;
Ulrike Stierschneider, Vienna, AT;
Alexander von Gabain, Vienna, AT;
Intercell AG, Vienna, AT;
Abstract
The present invention relates to isolated nucleic acid molecules which encode an antigen, a vector which comprises such nucleic acid molecule, and a host cell comprising such vector. Furthermore, the invention provides antigens from aspecies, as well as fragments and variants thereof, a process for producing such antigens, and a process for producing a cell, which expresses such antigen. Moreover, the present invention provides antibodies binding to such antigen, a hybridoma cell producing such antibodies, methods for producing such antibodies, a pharmaceutical composition comprising such nucleic acid molecule, antigen, vector or antibody, the use of such nucleic acid molecule, antigen, vector or antibody for the preparation of a pharmaceutical composition, methods for identifying an antagonist capable of binding such antigen or of reducing or inhibiting the interaction activity of such antigen, methods for diagnosing an infection and methods for the treatment or prevention of an infection. More specifically such antigens are produced by or associated with bacterial pathogens causing nosocomial infections or bacterial infections caused by